These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 37657859)

  • 21. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of histone modification with the development of schizophrenia.
    Chen YZ; Zhu XM; Lv P; Hou XK; Pan Y; Li A; Du Z; Xuan JF; Guo X; Xing JX; Liu K; Yao J
    Biomed Pharmacother; 2024 Jun; 175():116747. PubMed ID: 38744217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unraveling the epigenetic code of cancer for therapy.
    Smith LT; Otterson GA; Plass C
    Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin: An epigenetic regulator and its application in cancer.
    Ming T; Tao Q; Tang S; Zhao H; Yang H; Liu M; Ren S; Xu H
    Biomed Pharmacother; 2022 Dec; 156():113956. PubMed ID: 36411666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress.
    Neganova ME; Klochkov SG; Aleksandrova YR; Aliev G
    Semin Cancer Biol; 2022 Aug; 83():452-471. PubMed ID: 32814115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic Regulation of Chromatin in Prostate Cancer.
    Natesan R; Aras S; Effron SS; Asangani IA
    Adv Exp Med Biol; 2019; 1210():379-407. PubMed ID: 31900918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
    Cacabelos R
    Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation and chromatin modifiers in colorectal cancer.
    Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
    Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Histone Onco- Modifications Using Plant-Derived Products.
    Illam SP; Kandiyil SP; Raghavamenon AC
    Curr Drug Targets; 2021; 22(11):1317-1331. PubMed ID: 33461463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical regulation of epigenetic modifications: opportunities for new cancer therapy.
    Zheng YG; Wu J; Chen Z; Goodman M
    Med Res Rev; 2008 Sep; 28(5):645-87. PubMed ID: 18271058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe.
    Niu Y; Chen J; Qiao Y
    Front Immunol; 2022; 13():836223. PubMed ID: 35140725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers.
    Yen CY; Huang HW; Shu CW; Hou MF; Yuan SS; Wang HR; Chang YT; Farooqi AA; Tang JY; Chang HW
    Cancer Lett; 2016 Apr; 373(2):185-92. PubMed ID: 26808576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epigenetic mechanism of cardiac differentiation of stem cells].
    Zhu H; Liu Y; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1217-21. PubMed ID: 22246356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMPK: An Epigenetic Landscape Modulator.
    Gongol B; Sari I; Bryant T; Rosete G; Marin T
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility.
    Qureshi IA; Mehler MF
    Prog Brain Res; 2010; 186():77-95. PubMed ID: 21094887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention.
    Shukla S; Meeran SM; Katiyar SK
    Cancer Lett; 2014 Dec; 355(1):9-17. PubMed ID: 25236912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
    Santini V; Gozzini A; Ferrari G
    Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.